Source: centralcharts

Press Release: Biostem Technologies : BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development,

Read full article »
Biostem Technologies's Competitors | Biostem Technologies's News | Biostem Technologies's Financials
Stay up-to-date with the latest news on Biostem Technologies
Annual Revenue
$100-500M
Employees
1-25
Jason Matuszewski's photo - Interim-CEO of Biostem Technologies

Interim-CEO

Jason Matuszewski

CEO Approval Rating

81/100

Read more
Stay up-to-date with the latest news on Biostem Technologies